Gordon Ralph Corey, MD

Professor of Medicine
Gary Hock Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Research Professor of Global Health
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973

Publications

Jr, RCM, Corey, GR, and Grayson, ML. "Introduction: Fusidic acid enters the United States." Clinical Infectious Diseases 52, no. SUPPL. 7 (2011): S467-S468.

PMID
21546622
Full Text

Hannan, MM, Husain, S, Mattner, F, Danziger-Isakov, L, Drew, RJ, Corey, GR, Schueler, S, Holman, WL, Lawler, LP, Gordon, SM, Mahon, NG, Herre, JM, Gould, K, Montoya, JG, Padera, RF, Kormos, RL, Conte, JV, and Mooney, ML. "Working formulation for the standardization of definitions of infections in patients using ventricular assist devices." Journal of Heart and Lung Transplantation 30, no. 4 (2011): 375-384.

PMID
21419995
Full Text

Prokocimer, P, Bien, P, Surber, J, Mehra, P, DeAnda, C, Bulitta, JB, and Corey, GR. "Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections." Antimicrobial Agents and Chemotherapy 55, no. 2 (2011): 583-592.

PMID
21115795
Full Text

Rubinstein, E, Lalani, T, Corey, GR, Kanafani, ZA, Nannini, EC, Rocha, MG, Rahav, G, Niederman, MS, Kollef, MH, Shorr, AF, Lee, PC, Lentnek, AL, Luna, CM, Fagon, J-Y, Torres, A, Kitt, MM, Genter, FC, Barriere, SL, Friedland, HD, and Stryjewski, ME. "Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens." Clinical Infectious Diseases 52, no. 1 (2011): 31-40.

PMID
21148517
Full Text

Corey, GR, Wilcox, MH, Talbot, GH, Thye, D, Friedland, D, Baculik, T, and CANVAS 1 investigators, . "CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections." J Antimicrob Chemother 65 Suppl 4 (November 2010): iv41-iv51.

PMID
21115454
Full Text

Corey, GR, Wilcox, M, Talbot, GH, Friedland, HD, Baculik, T, Witherell, GW, Critchley, I, Das, AF, and Thye, D. "Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection." Clin Infect Dis 51, no. 6 (September 15, 2010): 641-650.

PMID
20695801
Full Text

Bennett-Guerrero, E, Pappas, TN, Koltun, WA, Fleshman, JW, Lin, M, Garg, J, Mark, DB, Marcet, JE, Remzi, FH, George, VV, Newland, K, Corey, GR, and SWIPE 2 Trial Group, . "Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery." N Engl J Med 363, no. 11 (September 9, 2010): 1038-1049.

PMID
20825316
Full Text

Bennett-Guerrero, E, Ferguson, TB, Lin, M, Garg, J, Mark, DB, Scavo, VA, Kouchoukos, N, Richardson, JB, Pridgen, RL, Corey, GR, and SWIPE-1 Trial Group, . "Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial." JAMA 304, no. 7 (August 18, 2010): 755-762.

PMID
20716738
Full Text

Nannini, EC, Stryjewski, ME, and Corey, GR. "Ceftaroline for complicated skin and skin-structure infections." Expert Opin Pharmacother 11, no. 7 (May 2010): 1197-1206.

PMID
20402556
Full Text

Nannini, EC, Stryjewski, ME, Singh, KV, Rude, TH, Corey, GR, Fowler, VG, and Murray, BE. "Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus." Antimicrob Agents Chemother 54, no. 5 (May 2010): 2206-2208.

PMID
20211890
Full Text

Pages